The most important factors in the management of scarlet fever are the early diagnosis of the disease and the administration of an adequate amount of scarlet fever antitoxin. If this is done, a favorable effect will be noted on the severity of the febrile stage of the disease, on the course and duration of the fever, on the intensity and duration of the skin lesions, and on the occurrence of complications. These statements are supported by numerous reports that have appeared in the literature during the last few years, and by a study of 2,303 cases of scarlet fever admitted to the Durand Hospital during the years 1924 to 1931 inclusive, in 882 of which scarlet fever antitoxin was administered. This study deals with the last group. The antitoxin used was commercial concentrated and refined serum, standardized by means of skin tests in susceptible persons. One therapeutic dose (sufficient antitoxin
HUNT LW. THE TREATMENT OF SCARLET FEVER WITH ANTITOXIN. JAMA. 1933;101(19):1444–1447. doi:10.1001/jama.1933.02740440004002
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: